- Home
- SNCR vs ABVC Comparison
SNCR vs ABVC Comparison
Compare SNCR & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNCR
- ABVC
- Stock Information
- Founded
- SNCR 2000
- ABVC 2015
- Country
- SNCR United States
- ABVC United States
- Employees
- SNCR N/A
- ABVC N/A
- Industry
- SNCR EDP Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SNCR Technology
- ABVC Health Care
- Exchange
- SNCR Nasdaq
- ABVC Nasdaq
- Market Cap
- SNCR 59.5M
- ABVC 68.7M
- IPO Year
- SNCR 2006
- ABVC N/A
- Fundamental
- Price
- SNCR $4.36
- ABVC $2.72
- Analyst Decision
- SNCR Strong Buy
- ABVC
- Analyst Count
- SNCR 1
- ABVC 0
- Target Price
- SNCR $13.00
- ABVC N/A
- AVG Volume (30 Days)
- SNCR 139.4K
- ABVC 60.9K
- Earning Date
- SNCR 11-04-2025
- ABVC 11-03-2025
- Dividend Yield
- SNCR N/A
- ABVC N/A
- EPS Growth
- SNCR N/A
- ABVC N/A
- EPS
- SNCR N/A
- ABVC N/A
- Revenue
- SNCR $170,909,000.00
- ABVC $797,916.00
- Revenue This Year
- SNCR $1.36
- ABVC $735.18
- Revenue Next Year
- SNCR $5.22
- ABVC N/A
- P/E Ratio
- SNCR N/A
- ABVC N/A
- Revenue Growth
- SNCR 0.07
- ABVC 56.52
- 52 Week Low
- SNCR $3.98
- ABVC $0.40
- 52 Week High
- SNCR $12.85
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- SNCR 38.01
- ABVC 41.56
- Support Level
- SNCR $3.98
- ABVC $2.77
- Resistance Level
- SNCR $5.79
- ABVC $3.06
- Average True Range (ATR)
- SNCR 0.41
- ABVC 0.18
- MACD
- SNCR -0.09
- ABVC -0.02
- Stochastic Oscillator
- SNCR 24.31
- ABVC 12.79
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.